Synopsys Valuation
Is SNPS * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of SNPS * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: SNPS * (MX$9500) is trading above our estimate of fair value (MX$4982.8)
Significantly Below Fair Value: SNPS * is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for SNPS *?
Other financial metrics that can be useful for relative valuation.
What is SNPS *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$86.45b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 14x |
Enterprise Value/EBITDA | 54.2x |
PEG Ratio | 4.4x |
Price to Earnings Ratio vs Peers
How does SNPS *'s PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 52.5x | ||
CDNS Cadence Design Systems | 75.1x | 16.7% | US$78.6b |
WDAY Workday | 49.5x | 13.6% | US$68.4b |
ROP Roper Technologies | 39.6x | 9.4% | US$58.0b |
DSY Dassault Systèmes | 45.9x | 13.9% | €49.7b |
SNPS * Synopsys | 61.4x | 14.0% | Mex$86.5b |
Price-To-Earnings vs Peers: SNPS * is expensive based on its Price-To-Earnings Ratio (61.4x) compared to the peer average (52.5x).
Price to Earnings Ratio vs Industry
How does SNPS *'s PE Ratio compare vs other companies in the Global Software Industry?
Price-To-Earnings vs Industry: SNPS * is expensive based on its Price-To-Earnings Ratio (61.4x) compared to the Global Software industry average (32.8x).
Price to Earnings Ratio vs Fair Ratio
What is SNPS *'s PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 61.4x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate SNPS *'s Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | Mex$9,500.00 | Mex$10,562.52 +11.2% | 7.1% | Mex$11,709.20 | Mex$8,009.71 | n/a | 17 |
May ’25 | n/a | Mex$10,501.99 0% | 6.9% | Mex$11,651.59 | Mex$7,970.30 | n/a | 18 |
Apr ’25 | n/a | Mex$10,444.55 0% | 7.0% | Mex$11,623.03 | Mex$7,950.77 | n/a | 17 |
Mar ’25 | Mex$9,905.00 | Mex$10,659.21 +7.6% | 6.9% | Mex$11,507.40 | Mex$8,183.04 | n/a | 15 |
Feb ’25 | n/a | Mex$10,526.86 0% | 7.9% | Mex$11,582.12 | Mex$8,236.18 | n/a | 14 |
Jan ’25 | Mex$9,100.00 | Mex$10,557.11 +16.0% | 7.4% | Mex$11,588.33 | Mex$8,240.59 | n/a | 15 |
Dec ’24 | Mex$9,570.00 | Mex$10,255.37 +7.2% | 10.7% | Mex$11,607.98 | Mex$8,254.56 | n/a | 15 |
Nov ’24 | n/a | Mex$9,316.45 0% | 8.9% | Mex$10,947.36 | Mex$7,663.15 | n/a | 15 |
Oct ’24 | Mex$7,789.32 | Mex$8,535.90 +9.6% | 4.9% | Mex$9,059.62 | Mex$7,388.43 | n/a | 14 |
Sep ’24 | Mex$7,877.00 | Mex$8,122.45 +3.1% | 4.9% | Mex$8,631.35 | Mex$7,039.16 | n/a | 14 |
Aug ’24 | n/a | Mex$7,725.68 0% | 7.9% | Mex$8,543.01 | Mex$6,398.88 | n/a | 14 |
Jul ’24 | n/a | Mex$7,784.32 0% | 7.5% | Mex$8,623.63 | Mex$6,523.22 | n/a | 14 |
Jun ’24 | Mex$7,980.42 | Mex$7,712.15 -3.4% | 6.0% | Mex$8,548.08 | Mex$6,732.71 | n/a | 14 |
May ’24 | n/a | Mex$7,641.45 0% | 5.3% | Mex$8,398.01 | Mex$6,869.47 | n/a | 14 |
Apr ’24 | Mex$6,790.00 | Mex$7,822.89 +15.2% | 5.3% | Mex$8,597.42 | Mex$7,032.58 | n/a | 14 |
Mar ’24 | Mex$6,541.58 | Mex$7,822.89 +19.6% | 5.3% | Mex$8,597.42 | Mex$7,032.58 | Mex$9,905.00 | 14 |
Feb ’24 | Mex$6,660.00 | Mex$7,811.77 +17.3% | 6.6% | Mex$8,760.59 | Mex$6,695.19 | n/a | 14 |
Jan ’24 | Mex$6,135.95 | Mex$8,164.74 +33.1% | 6.6% | Mex$9,187.94 | Mex$7,021.79 | Mex$9,100.00 | 15 |
Dec ’23 | Mex$6,770.00 | Mex$7,938.76 +17.3% | 6.9% | Mex$8,945.71 | Mex$6,675.76 | Mex$9,570.00 | 15 |
Nov ’23 | n/a | Mex$8,189.30 0% | 8.2% | Mex$9,107.96 | Mex$6,866.00 | n/a | 14 |
Oct ’23 | n/a | Mex$8,277.93 0% | 8.0% | Mex$9,155.97 | Mex$6,902.19 | Mex$7,789.32 | 15 |
Sep ’23 | n/a | Mex$8,310.74 0% | 7.4% | Mex$9,154.05 | Mex$6,900.75 | Mex$7,877.00 | 12 |
Aug ’23 | Mex$7,436.12 | Mex$7,839.01 +5.4% | 7.2% | Mex$9,107.99 | Mex$6,836.11 | n/a | 11 |
Jul ’23 | n/a | Mex$7,638.90 0% | 7.1% | Mex$8,958.25 | Mex$6,723.72 | n/a | 13 |
Jun ’23 | Mex$5,820.00 | Mex$7,481.08 +28.5% | 7.9% | Mex$8,864.04 | Mex$6,473.74 | Mex$7,980.42 | 14 |
May ’23 | n/a | Mex$7,855.27 0% | 8.3% | Mex$8,987.75 | Mex$6,564.09 | n/a | 14 |
Analyst Forecast: Target price is less than 20% higher than the current share price.